BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29856219)

  • 21. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
    Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
    Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling.
    Egertová M; Cravatt BF; Elphick MR
    Neuroscience; 2003; 119(2):481-96. PubMed ID: 12770562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer activity of anandamide in human cutaneous melanoma cells.
    Adinolfi B; Romanini A; Vanni A; Martinotti E; Chicca A; Fogli S; Nieri P
    Eur J Pharmacol; 2013 Oct; 718(1-3):154-9. PubMed ID: 24041928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
    Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors.
    Deplano A; Cipriano M; Moraca F; Novellino E; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):562-576. PubMed ID: 30688118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible endocannabinoid control of colorectal cancer growth.
    Ligresti A; Bisogno T; Matias I; De Petrocellis L; Cascio MG; Cosenza V; D'argenio G; Scaglione G; Bifulco M; Sorrentini I; Di Marzo V
    Gastroenterology; 2003 Sep; 125(3):677-87. PubMed ID: 12949714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
    Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
    Cravatt BF; Lichtman AH
    Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.
    Winkler K; Ramer R; Dithmer S; Ivanov I; Merkord J; Hinz B
    Oncotarget; 2016 Mar; 7(12):15047-64. PubMed ID: 26930716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells.
    Gasperi V; Fezza F; Spagnuolo P; Pasquariello N; Maccarrone M
    Neurotoxicology; 2005 Oct; 26(5):811-7. PubMed ID: 16154199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinspired-Metalloporphyrin Magnetic Nanocomposite as a Reusable Catalyst for Synthesis of Diastereomeric (-)-Isopulegol Epoxide: Anticancer Activity Against Human Osteosarcoma Cells (MG-63).
    Dias LD; Batista de Carvalho ALM; Pinto SMA; Aquino GLB; Calvete MJF; Rossi LM; Marques MPM; Pereira MM
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30586854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
    Fichna J; Sałaga M; Stuart J; Saur D; Sobczak M; Zatorski H; Timmermans JP; Bradshaw HB; Ahn K; Storr MA
    Neurogastroenterol Motil; 2014 Apr; 26(4):470-81. PubMed ID: 24460851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Epoxides of Soloxolone Methyl: An Effect of the Formation of Oxirane Ring and Stereoisomerism on Cytotoxic Profile, Anti-Metastatic and Anti-Inflammatory Activities In Vitro and In Vivo.
    Salomatina OV; Sen'kova AV; Moralev AD; Savin IA; Komarova NI; Salakhutdinov NF; Zenkova MA; Markov AV
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis.
    Feledziak M; Lambert DM; Marchand-Brynaert J; Muccioli GG
    Recent Pat CNS Drug Discov; 2012 Apr; 7(1):49-70. PubMed ID: 22280341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
    Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
    Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
    Mol Pain; 2016; 12():. PubMed ID: 27178246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
    Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.